- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Aventura Hospital and Medical Center
Totalt 10289 resultater
-
Tianjin Medical University Cancer Institute and...UkjentBruk av flere stofferKina
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...UkjentPostoperative komplikasjoner
-
Tianjin Medical University Cancer Institute and...UkjentKarsinom, ikke-småcellet lungeKina
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...TilbaketrukketBukspyttkjertelkreftKina
-
Tianjin Medical University Cancer Institute and...FullførtIkke småcellet lungekreftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringHepatocellulært karsinom | Hepatocellulært karsinom Ikke-resektabeltKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåIntrahepatisk kolangiokarsinomKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåAvansert/metastatisk tykktarmskreftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringBildekvalitet og konturnøyaktighet av svulsten i strålebehandlingKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMagekreft | No.12a LymfeknutedisseksjonKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMagekreft | Prediktiv kreftmodell | LevermetastaseKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringBukspyttkjertelkreft | Prediktiv kreftmodellKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåPDAC - Pancreatic Ductal Adenocarcinoma
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåIkke småcellet lungekreft tilbakevendende
-
Tianjin Medical University Cancer Institute and...RekrutteringAvansert galleveiskreftKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennå
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåNSCLC | EGFR-aktiverende mutasjon | Anlotinib | TP53 | Aumolertinib
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringIntrahepatisk kolangiokarsinom | Durvalumab | GemcisKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennå
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennå
-
Tianjin Medical University Cancer Institute and...RekrutteringPlateepitelkarsinom i hode og nakke | Neoadjuvant kjemoterapiKina
-
Tianjin Medical University Cancer Institute and...Har ikke rekruttert ennåEsophageal plateepitelkarsinom
-
Tianjin Medical University Cancer Institute and...RekrutteringKonvertering av Tislelizumab kombinert med kjemoterapi ved uoperabelt esophageal plateepitelkarsinomUopprettelig | Esophageal plateepitelkarsinom av AJCC V8 StageKina
-
Tianjin Medical University Cancer Institute and...RekrutteringKjemoterapi-indusert kvalme og oppkastKina
-
Tianjin Medical University Cancer Institute and...RekrutteringKarsinom, ikke-småcellet lunge | EGF-R positiv ikke-småcellet lungekreft | Bevacizumab | Tyrosinkinase-hemmerKina
-
Tianjin Medical University Cancer Institute and...RekrutteringFørstelinjebehandling | Avansert gastrisk karsinomKina
-
Tianjin Medical University Cancer Institute and...RekrutteringAvansert HER2 negativ brystkarsinom | HRD+brystkreftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMSI-H avansert tykktarmskreftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringHepatocellulært karsinomKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringTykktarmskreft | Immunterapi | MSI-H | Adjuvant terapiKina
-
Tianjin Medical University Cancer Institute and...RekrutteringLokalt avansert livmorhalskreftKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringPembrolizumab | Neoadjuvant kjemoterapi | Adenokarsinom i Esophagogastric JunctionKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMagekreft | Peristaltisk retning | Roux-en-Y Gastrointestinal anastomoseKina
-
Tianjin Medical University Cancer Institute and...RekrutteringSintilimab, Cetuximab, Regorafenib, Combine, mCRCKina
-
Tianjin Medical University Cancer Institute and...RekrutteringResektabelt hepatocellulært karsinomKina
-
Tianjin Medical University Cancer Institute and...RekrutteringLungeneoplasmer | Eksisjon av lymfeknuteKina
-
Tianjin Medical University Cancer Institute and...RekrutteringBrystkreft | Fulvestrant | PalbociclibKina
-
Tianjin Medical University Cancer Institute and...RekrutteringKolangiokarsinom | GalleblærekarsinomKina
-
Tianjin Medical University Cancer Institute and...FullførtEsophageal plateepitelkarsinomKina
-
Tianjin Medical University Cancer Institute and...Aktiv, ikke rekrutterendeMagekreft stadium IVKina